Apr 15, 2026
Many patients stop GLP-1 drugs (Ozempic, Wegovy, Zepbound) within a year and often plan to restart; health effects of cycling are not well studied
Insurance-claims research published as a JAMA research letter found that fewer than one in four patients remained on a GLP-1 medication after one year. Clinicians ci...
